<DOC>
	<DOCNO>NCT00553137</DOCNO>
	<brief_summary>A prospective randomize double blind placebo control comparative trial perform HIV clinic Muhimbili National Hospital/MUCHS 220 HIV positive patient present oropharyngeal candidiasis ( OPC ) antiretroviral ( ARVs ) treatment include . The aim study compare efficacy safety single dose fluconazole ( 750mg ) two week course fluconazole ( 150mg daily ) treatment OPC HIV positive patient . It hypothesise two regimen equally effective treatment OPC .</brief_summary>
	<brief_title>Single Dose Versus Two Weeks Course Fluconazole Treatment Oropharyngeal Candidiasis HIV Infected Individuals Tanzania</brief_title>
	<detailed_description>A structured standard questionnaire use systematically collect essential data include demography , treatment history concomitant infection treatment . General oral examination , collection oral isolates , mycological , hematological biochemical investigation do baseline end treatment day 13-14 . All Patients follow 30 day end treatment relapse</detailed_description>
	<mesh_term>Candidiasis</mesh_term>
	<mesh_term>Fluconazole</mesh_term>
	<criteria>HIV infection ( determine positive ELISA confirm Western blot ) 18 year age clinical picture OPC , characterize creamy , white , curd like patch , removable scrap typical erythematous lesion ( smooth red patch ) oral mucosa , hard soft palate and/or dorsal surface tongue ; microbiologically visualization yeast cell Potassium hydroxide ( 10 % KOH ) preparation prepare swab visible lesion confirm positive Candida specie culture Patients currently receive antifungal therapy receive treatment within three day prior enrollment study History allergy azole derivative Abnormal liver function test define alanine aminotransferase ( ALT ) , aspartate aminotransferase ( AST ) , total bilirubin great three time upper limit normal ; clinical evidence significant hepatic renal disease within two month prior enrollment Inability tolerate oral drug administration ; pregnancy breast feeding ; life expectancy less four week Participation another drug study time enrollment , treatment drug interact fluconazole , vitamin K antagonist , warfarin , sulfonylurea antidiabetic agent , rifampicin , phenytoin , isoniazid , carbamazepine cisapride Documented systemic fungal infection , symptom suggestive esophageal candidiasis retrosternal chest pain , dysphagia odynophagia unless condition rule endoscopic examination . Patients history alcohol abuse , drug addiction psychiatric disorder , inability cooperate poor motivation exclude study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>oropharyngeal candidiasis</keyword>
</DOC>